FDA Clears Four Drug Products for Sale, Citing Lack of Safety or Effectiveness Concerns

Summary

The US Food and Drug Administration (FDA) has ruled that four pharmaceutical products, including Trilafon tablets, were not removed from the market due to safety or efficacy concerns, leaving their approval status intact.